224 related articles for article (PubMed ID: 33886060)
1. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
Alenabi A; Malekinejad H
Mol Cell Biochem; 2021 Sep; 476(9):3285-3301. PubMed ID: 33886060
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the CB
Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
[TBL] [Abstract][Full Text] [Related]
3. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cannabinoid CB
Salort G; Álvaro-Bartolomé M; García-Sevilla JA
Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
[TBL] [Abstract][Full Text] [Related]
6. Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.
Feng R; Tong Q; Xie Z; Cheng H; Wang L; Lentzsch S; Roodman GD; Xie XQ
Mol Carcinog; 2015 Dec; 54(12):1796-806. PubMed ID: 25640641
[TBL] [Abstract][Full Text] [Related]
7. Cannabichromene is a cannabinoid CB
Udoh M; Santiago M; Devenish S; McGregor IS; Connor M
Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508
[TBL] [Abstract][Full Text] [Related]
8. CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development.
Mlost J; Kostrzewa M; Borczyk M; Bryk M; Chwastek J; Korostyński M; Starowicz K
Biomed Pharmacother; 2021 Apr; 136():111283. PubMed ID: 33482616
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.
Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
Eur Neuropsychopharmacol; 2013 Jul; 23(7):760-7. PubMed ID: 22841827
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage.
Tan Q; Chen Q; Feng Z; Shi X; Tang J; Tao Y; Jiang B; Tan L; Feng H; Zhu G; Yang Y; Chen Z
Brain Res; 2017 Jan; 1654(Pt A):24-33. PubMed ID: 27769788
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer effects of selective cannabinoid agonists in pancreatic and breast cancer cells.
Turgut NH; Armagan G; Kasapligil G; Erdogan MA
Bratisl Lek Listy; 2022; 123(11):813-821. PubMed ID: 36254639
[TBL] [Abstract][Full Text] [Related]
13. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.
Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy.
Liu Q; Wu Z; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Wang W; Chen S; Zhou N; Li Y; Shi B
Neurourol Urodyn; 2020 Jan; 39(1):158-169. PubMed ID: 31729056
[TBL] [Abstract][Full Text] [Related]
15. Optical Control of Cannabinoid Receptor 2-Mediated Ca
Sarott RC; Viray AEG; Pfaff P; Sadybekov A; Rajic G; Katritch V; Carreira EM; Frank JA
J Am Chem Soc; 2021 Jan; 143(2):736-743. PubMed ID: 33399457
[TBL] [Abstract][Full Text] [Related]
16. The Cannabinoid-2 receptor agonist, 1-phenylisatin, protects against cisplatin-induced nephrotoxicity in mice.
Chafik SG; Michel HE; El-Demerdash E
Life Sci; 2022 Nov; 308():120928. PubMed ID: 36058263
[TBL] [Abstract][Full Text] [Related]
17. Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.
Capozzi A; Mattei V; Martellucci S; Manganelli V; Saccomanni G; Garofalo T; Sorice M; Manera C; Misasi R
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973514
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of cannabinoid type II receptor agonist AM1241 on ConA-induced liver injury in mice via mitogen-activated protein kinase signalling pathway.
Wu Y; Ma R; Long C; Shu Y; He P; Zhou Y; Xiang Y; Wang Y
Int J Immunopathol Pharmacol; 2021; 35():20587384211035251. PubMed ID: 34384259
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
